Nevro Corp.
NVRO
$5.79
$0.010.17%
| Weiss Ratings | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.08 | |||
| Price History | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.05% | |||
| 30-Day Total Return | 14.43% | |||
| 60-Day Total Return | 37.20% | |||
| 90-Day Total Return | 7.22% | |||
| Year to Date Total Return | 56.06% | |||
| 1-Year Total Return | -59.62% | |||
| 2-Year Total Return | -80.96% | |||
| 3-Year Total Return | -90.34% | |||
| 5-Year Total Return | -94.25% | |||
| 52-Week High % Change | -61.13% | |||
| 52-Week Low % Change | 82.62% | |||
| Price | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $14.87 | |||
| 52-Week Low Price | $3.17 | |||
| 52-Week Low Price (Date) | Jan 10, 2025 | |||
| 52-Week High Price (Date) | Mar 13, 2024 | |||
| Valuation | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 218.94M | |||
| Enterprise Value | 177.89M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.05 | |||
| Earnings Per Share Growth | 18.73% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.53 | |||
| Price/Book (Q) | 0.95 | |||
| Enterprise Value/Revenue (TTM) | 0.44 | |||
| Price | $5.79 | |||
| Enterprise Value/EBITDA (TTM) | -2.12 | |||
| Enterprise Value/EBIT | -1.88 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 37.62M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 251 0005 | |||
| Address | 1800 Bridge Parkway Redwood City, CA 94065 | |||
| Website | nevro.com | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -23.18% | |||
| Profit Margin | -27.76% | |||
| Management Effectiveness | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -9.95% | |||
| Return on Equity | -- | |||
| Income Statement | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 408.52M | |||
| Total Revenue (TTM) | 408.52M | |||
| Revenue Per Share | $10.86 | |||
| Gross Profit (TTM) | 269.53M | |||
| EBITDA (TTM) | -83.80M | |||
| EBIT (TTM) | -94.70M | |||
| Net Income (TTM) | -113.44M | |||
| Net Income Avl. to Common (TTM) | -113.44M | |||
| Total Revenue Growth (Q YOY) | -9.15% | |||
| Earnings Growth (Q YOY) | -491.37% | |||
| EPS Diluted (TTM) | -3.05 | |||
| EPS Diluted Growth (Q YOY) | -470.72% | |||
| Balance Sheet | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 292.53M | |||
| Cash Per Share (Q) | $7.78 | |||
| Total Current Assets (Q) | 476.00M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 231.01M | |||
| Current Ratio (Q) | 4.624 | |||
| Book Value Per Share (Q) | $6.11 | |||
| Total Assets (Q) | 553.84M | |||
| Total Current Liabilities (Q) | 102.94M | |||
| Total Debt (Q) | 251.48M | |||
| Total Liabilities (Q) | 322.83M | |||
| Total Common Equity (Q) | 231.01M | |||
| Cash Flow | NVRO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 14.63M | |||
| Cash from Financing (TTM) | -4.21M | |||
| Net Change in Cash (TTM) | -9.77M | |||
| Levered Free Cash Flow (TTM) | -4.77M | |||
| Cash from Operations (TTM) | -19.44M | |||
